ET190L1 ARTEMIS T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ET190L1 ARTEMIS T Cells, covering 2019-02-04 to 2019-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of ET190L1 ARTEMIS™ T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma [Phase 1]